GlobeNewswire

Hitachi Vantara Unveils Industry Leading AI Operations Software and New Flash Storage Systems

Dela

New Systems With Predictive Analytics and IT Automation Software Deliver Agile Data Infrastructure and Intelligent Operations to Fuel Data Center Modernization Initiatives

SANTA CLARA, Calif., May 09, 2018 (GLOBE NEWSWIRE) -- Hitachi Vantara, a wholly owned subsidiary of Hitachi, Ltd. (TSE:6501), today introduced new innovations to drive data center modernization. Hitachi unveiled new high-performance storage systems in the industry's only storage family with a 100% data availability guarantee, and integrated, and cross-platform AI-powered analytics and IT automation software. The all-new, all-flash and hybrid Hitachi Virtual Storage Platform (VSP) systems and AI operations software give customers unprecedented agility and automation to reduce costs and increase operational efficiencies-the foundation for any modern data center initiative. Developers will gain increased flexibility and can now run more workloads in a single system through Docker and Redhat Openshift container integration with Swarm and Kubernetes orchestration.

>> View the Hitachi Vantara Data Center Modernization video with Bob Madaio, vice president, infrastructure solutions marketing at Hitachi Vantara <<

"As artificial intelligence and machine-learning technologies mature, enterprise storage vendors have an opportunity to provide considerable assistance to customers on their journey to autonomous operations," said Eric Burgener, research vice president of Storage at IDC. "Vendors like Hitachi Vantara, with their enhanced AI operations portfolio, are leveraging AI/ML to simplify infrastructure management while improving platform reliability, infrastructure efficiency and the ability to meet service level agreements."

Intelligent Operations 
As data center operations become more complex, operational efficiencies can deteriorate and the risks of downtime or data loss increase. Hitachi Vantara is introducing the industry's most advanced AI operations software portfolio, which includes Hitachi Infrastructure Analytics AdvisorHitachi Automation Director and Hitachi Data Instance Director to deliver a more agile data infrastructure.

Hitachi Infrastructure Analytics Advisor (HIAA) delivers an AI-powered "brain" to provide deeper data center insights by looking across the data path, including virtual machines, servers, networks and storage. HIAA uses machine learning to more efficiently optimize, troubleshoot and predict data center needs. New HIAA capabilities include:

  • Predictive analytics: AI mines telemetry data to predict when new storage purchases will be required, improving budget planning and helping to prevent performance dips. Machine learning analyzes all resources associated with storage to help ensure the right resource is purchased.
  • 4x faster root-cause analysis: A patented AI engine analyzes telemetry data and configuration changes across the data path to isolate issues and uses a new heuristic engine to recommend resolution. Integration with Hitachi Automation Director allows immediate fixes based on best practices.

Hitachi Automation Director (HAD) software provides an "engine" for orchestrating the delivery and management of IT resources so that teams can focus on innovation. A highly customizable solution, HAD automates core IT service delivery routines including virtual machine, network zoning and storage and data protection tasks to reduce errors that impact uptime, customer experiences and return on investment (ROI). HAD has been enhanced to:

  • Integrate with IT service management (ITSM) tools, including the ServiceNow® platform, for improved tracking and control of IT resource delivery.
  • Improve REST API integration for provisioning of third-party resources, including storage.
  • Take commands from HIAA for issue remediation and storage configuration data.
  • Automate the setup of Hitachi Data Instance Director (HDID) data protection to safeguard against data loss or downtime.  

The new integrations between HIAA, HAD and HDID are part of Hitachi's growing AI operations initiative to help customers begin the journey to autonomous operations. These offerings are now available both independently and packaged together with Hitachi VSP to help customers easily get the tools that drive data center modernization.

"VMware and Hitachi are working together to bring a new operational model to the data center," said Lee Caswell, vice president, Product, Storage and Availability Business Unit, VMware. "Our joint integration work helps Hitachi VSP customers seamlessly leverage many VMware solutions including VMware vSphere, Virtual Volumes and Site Recovery Manager to simplify daily operations and disaster recovery scenarios. And by sharing telemetry data between Hitachi AI operations software and vCenter-native management tools, we help customers digitally transform their business and realize the power of modern infrastructure." 

Agile Data Infrastructure
Data center modernization begins with a rock-solid foundation for consistent delivery of data at high speed and low latency, with support for diverse workload requirements and multi-cloud integration. Hitachi's new all-flash VSP F series and hybrid-flash VSP G seriessystems support an agile data infrastructure with the industry's only 100% data availability guarantee and up to 3x more IOPS performance and 2.5x greater scalability compared to prior VSP models. This means customers can expect faster analytics processing and application performance - fueling a faster return on data. Cloud and container integration allow more workloads to run on a single system, while helping to eliminate data silos and support new workloads.

The new enterprise-class Hitachi VSP models include the all-flash VSP F700 and VSP F900 and the hybrid flash VSP G700 and G900 systems. To reach a broader range of customers, Hitachi is introducing new midrange models. They include the VSP F350, F370, G350 and G370 systems. The systems are powered by the next generation of Hitachi Storage Virtualization Operating System, SVOS RF, which has been re-architected for increased performance, scalability and data efficiency. All new VSP systems are backed by Hitachi's new flat service model and come with a Foundation software package that includes Hitachi's proven infrastructure analytics and copy data management software. All new Hitachi VSP systems are available now.

The new systems have significant improvements compared to prior VSP models:

  • Performance scalability: Scaling to more than 2.4M IOPS and 41GB/s of bandwidth.
  • More efficiency: Up to 70% more IOPS per core for increased price/performance.
  • Greater consolidation: 8x more volumes and one million snapshots per system.
  • Improved data efficiency: Up to 3.4x faster deduplication and 5x faster SVOS-based compression.

"Hitachi is helping the world's business and IT leaders respond to modern data challenges by leveraging predictive analytics and automation as part of their larger data management and digital transformation initiatives," said Iri Trashanski, senior vice president, Infrastructure and Edge Products at Hitachi Vantara. "With the criticality of data in our customers' environments, there is no room for good-enough storage technology or data-silos created by weak infrastructure. The technology announced today will help create the agile data infrastructure and intelligent operations our customers need to drive transformation."

About Hitachi Vantara
Hitachi Vantara, a wholly owned subsidiary of Hitachi, Ltd., helps data-driven leaders find and use the value in their data to innovate intelligently and reach outcomes that matter for business and society. We combine technology, intellectual property and industry knowledge to deliver data-managing solutions that help enterprises improve their customers' experiences, develop new revenue streams, and lower the costs of business. Only Hitachi Vantara elevates your innovation advantage by combining deep information technology (IT), operational technology (OT) and domain expertise. We work with organizations everywhere to drive data to meaningful outcomes. Visit us at www.hitachivantara.com.

Connect with Hitachi Vantara

About Hitachi, Ltd.
Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society's challenges, combining its operational technology, information technology, and products/systems. The company's consolidated revenues for fiscal 2017 (ended March 31, 2018) totaled 9,368.6 billion yen ($88.4 billion). The Hitachi Group is an innovation partner for the IoT era, and it has approximately 307,000 employees worldwide. Through collaborative creation with customers, Hitachi is deploying Social Innovation Business using digital technologies in a broad range of sectors, including Power/Energy, Industry/Distribution/Water, Urban Development, and Finance/Social Infrastructure/Healthcare. For more information on Hitachi, please visit the company's website at http://www.hitachi.com.

HITACHI is a trademark or registered trademark of Hitachi, Ltd. All other trademarks, service marks, and company names are properties of their respective owners.

PRESS CONTACT
Brian Garabedian
Hitachi Vantara
brian.garabedian@hitachivantara.com
408- 970-7572




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Hitachi Vantara via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Immunicum AB (publ) Announces Upcoming Investor Events in October and November22.10.2018 16:00Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Announces Upcoming Investor Events in October and November Immunicum AB (publ; IMMU.ST) announced today that the Company will participate in and host investor events in October and November. At all events Carlos de Sousa, CEO of Immunicum, and other members of the management team, will provide a corporate presentation and be available for a question and answer session. BioStock Life Science Summit Date: October 25, 2018 Presentation Time: 18.50 Central European Time Venue: Medicon Village, Scheelevägen 2, Building 302-auditorium, Lund, Sweden Registration Link: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicum Investor Event - Gothenburg Date: October 29, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venue: First Hotel G, Nils Ericsonplatsen, 411 03 Gothenburg, Sweden Immunicum Investor Event - Stockholm Date: October 30, 2018 Presentation Time: 17.30 - 20.00 Central European Time Venu

Immunicum AB (publ) meddelar kommande investerarevent under oktober och november22.10.2018 16:00Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) meddelar kommande investerarevent under oktober och november Immunicum AB (publ; IMMU.ST) meddelar i dag att bolaget kommer att anordna och delta i investerarträffar under oktober och november. Vid samtliga event kommer Carlos de Sousa, Immunicums VD, och övriga medlemmar av ledningsgruppen, att hålla en presentation av bolaget och vara tillgängliga för att svara på frågor. BioStock Life Science Summit Datum: 25 oktober 2018 Presentationstid: Kl. 18.50 CET Plats: Medicon Village, Scheelevägen 2, byggnad 302 - hörsalen, Lund Länk för registrering: https://www.eventbrite.com/e/biostock-life-science-summit-tickets-51114333347 Immunicums investerarevent - Göteborg Datum: 29 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: First Hotel G, Nils Ericsonplatsen, 411 03, Göteborg Immunicums investerarevent - Stockholm Datum: 30 oktober 2018 Presentationstid: Kl. 17.30 - 20.00 CET Plats: Ingenjörshuset Citykonferensen, Plan 1, Malmski

Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress22.10.2018 12:45Pressmeddelande

Pressmeddelande 22 oktober 2018 Immunicum AB (publ) presenterar prekliniska resultat för ilixadencel i kombination med checkpointhämmare och immunaktiverare på 2018 års ESMO-kongress -- Intratumoral behandling med ilixadencel, en cellbaserad, lagringsbar immunaktiverare, ger en synergistisk antitumöreffekt och förstärker effekten av behandling med anti-PD-1 och anti-CD137 i djurmodeller -- Immunicum AB (publ; IMMU.ST) presenterar under 2018 års ESMO kongress (European Society for Medical Oncology) prekliniska resultat som visar en synergistisk anti-tumöreffekt när bolagets ledande produkt ilixadencel ges i kombination med en checkpointhämmare eller immunaktiverare. Resultaten från studien, som presenteras på en poster, visar att intratumoralt administrerat ilixadencel kan förstärka anti-tumörsvar och överlevnad vid behandling med checkpointhämmare eller immunaktiverare. Detta visar på potentialen hos ilixadencel att bli en komplementerande verkningsmekanism till flera olika framtida im

Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 201822.10.2018 12:45Pressmeddelande

Press Release 22 October 2018 Immunicum AB (publ) Presents Preclinical Results of Ilixadencel in Combination with Checkpoint Inhibitors and Immune Enhancers at ESMO 2018 -- Intratumoral treatment with ilixadencel, an off-the-shelf cell-based immune primer, provides synergistic anti-tumor effect and enhances efficacy of anti-PD-1 and anti-CD137 treatment in animal model -- Immunicum AB (publ; IMMU.ST) announced today the presentation of preclinical results that showed anti-tumor synergy between its lead product ilixadencel and a checkpoint inhibitor or an immune enhancer in a poster at the European Society for Medical Oncology (ESMO) 2018 Congress. The results of the study highlight the ability of intratumoral ilixadencel to enhance anti-tumor response and survival of systemic checkpoint inhibitors (anti-PD-1) or immune enhancers (anti-CD137/4-1BB). This emphasizes the potential for ilixadencel in multiple future immuno-oncology combination strategies by incorporating complementary mech

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug22.10.2018 09:00Pressmeddelande

STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and sales of the product in US. The implant is the first product of its kind in the US market. Cranioplug is an implant used during neurosurgical procedures. The product is intended to cover and plug holes drilled into the skull during surgery and to reattach cranial bone removed during surgery. Cranioplug resorbs and is replaced with bone during the healing process. Anders Lundqvist, CEO of OssDsign, said: "Receiving clearance for Cranioplug is an important step for OssDsign. This motivates us to increase our presence in the US market and continue to build our US organization throughout 2018 and beyond. The regenerative features of OssDsign's calcium phosphate composition are now getting recognized, and it's our mission to turn them into real benefits for patients, surgeons and hospital systems."

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum